Medical Advocates
Elvitegravir 150 mg (E), Cobicistat 150 mg (C), Emtricitabine 200 mg (F),
and Tenofovir Alafenamide 10 mg
(E/C/F/TAF) (Genvoya®)
Genvoya®
Genvoya®
  Main Page

New and Noteworthy
Journal Data
Elvitegravir/Tenofovir DF/Emtricitabine/Cobicistat
FDA Approval

 
 

ARV Main Page  Main New/Newsworthy 

Home Page

           

Last Update:  July 22, 2016 
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy
     

March 2016
 

Journal Papers, Abstracts, and Commentaries
 

 

FDA Approval
     


ARV Main Page  Main New/Newsworthy 

Home Page

           

Elvitegravir 150 mg (E), Cobicistat 150 mg (C), Emtricitabine 200 mg (F),
and Tenofovir Alafenamide 10 mg
(E/C/F/TAF) (Genvoya®)